Delivery Order SPE2DB22D2206-SPE2DB24FET48
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tobramycin 300 mg/5 ml ampules. The contract has a potential value of $4,188.53 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs. This...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Tobramycin 300 mg/5 ml ampules. The $1,007.78 firm-fixed-price contract has a completion date of January 27, 2022 and was awarded on January 26, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,219.89 contract is for the provision of Tobramycin 300 mg/5 ml ampules with a completion date of March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobramycin 300 mg/5 ml ampules, a pharmaceutical product, with a ceiling value of $3,579.54 and a completion date of April 1, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) contract with a ceiling value of $10,518.05. The contract was awarded by the Defense Logistics Agency (DLA) on June 25, 2021, with a period of performance through June 28, 2021. The contract is for the provision of pharmaceutical products and medical supplies to support the DLA's Troop Support Medical branch. The contract is a Firm Fixed Price (FFP) agreement and was not designated...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $6,022.37 and is a firm fixed-price delivery order with a completion date of February 23, 2024. The contract is for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Delivery Order under a prime vendor contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $82,226.70 and an ultimate completion date of July 9, 2020. It is a Firm Fixed Price contract for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. The contract was awarded on July 8, 2020 and was not set...
- The Department of Defense's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a delivery order contract valued at $2,030.70 for pharmaceutical products. The contract has a completion date of February 23, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen holds a much larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,723.00 firm-fixed-price delivery order contract is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FT04T) valued at $19,051.30 for the supply of Spiriva 18 mcg capsules. The contract was awarded on June 16, 2022 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 17, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FET48Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,163,907 units of the pharmaceutical product Tobi Podhaler 28 mg Inhale Cap UD 56s. The contract has a ceiling value of $31,358.30 and an ultimate completion date of December 22, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on December 21, 2022 and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.4k | 12/21/23 |